Frontlight ResearchEarly access
Trial site
Kanizsai Dorottya Korhaz
- 6running trials
- 9closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Type 2 diabetes5 trials
- Asthma3 trials
- Chronic kidney disease2 trials
- Stroke2 trials
- Atrial fibrillation1 trial
- COPD1 trial
- Heart failure1 trial
- Migraine1 trial
- Obesity1 trial
- Type 1 diabetes1 trial
- Phase
- Phase 310 trials
- Phase 24 trials
- Status
- Completed9 trials
- Recruiting3 trials
- Not yet recruiting2 trials
- Active, not recruiting1 trial
- Lead sponsor
- Eli Lilly and Company3 trials
- Bayer2 trials
- Novartis Pharmaceuticals2 trials
- Novo Nordisk A/S2 trials
- Pfizer Inc.2 trials
- and 4 more
Running trials
Not yet recruiting
Recruiting
Active, not recruiting
A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine
Recruiting
Investigation of Fixed Triple Inhaled Combination in Asthmatic Patients, in a Real-life Setting
Recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Asthma3 recruiting
- Chronic kidney disease1 recruiting
- COPD1 recruiting
- Obesity1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Not yet recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026